Literature DB >> 17720656

Analysis of fiducial markers used for on-line verification in the external-beam radiotherapy of patients with cranial tumours.

R Ma Cañón1, I Azinovic, M Lobato, J Navarro, J Rebollo.   

Abstract

PURPOSE: Evaluate the fiducial marker-based position verification in the external-beam radiotherapy of patients with cranial tumour.
METHODS: Thirteen patients with intracranial tumours were treated with external- beam radiotherapy using 3 gold markers implanted in the skull. Before each fraction the patient was positioned on the treatment table and 2 orthogonal portal images were performed to localise the 3 gold seeds and the target position was calculated using a commercialised computer program (ISOLOC software, MEDTEC). This program provides the couch movements required to move the target to the isocentre.
RESULTS: When the set-up error was corrected using the coordinates of the 3 markers, the final movements were less than 2 mm in all cases: lateral, mean v., 1.21 mm; longitudinal, 1.23 mm; and anteroposterior, 1.18 mm. No serious complications related to the gold marker insertion were noted.
CONCLUSION: The use of 3 implanted fiducial seeds is an optimal technique for precise set-up in patients with brain tumours treated with external radiotherapy. This commercial system is highly suitable for fractionated stereotactic irradiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720656     DOI: 10.1007/s12094-007-0097-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  21 in total

1.  (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device.

Authors:  Jean Pouliot; Michele Aubin; Katja M Langen; Yu-Ming Liu; Barby Pickett; Katsuto Shinohara; Mack Roach
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

2.  Introduction of a novel dose saving acquisition mode for the PortalVision aS500 EPID to facilitate on-line patient setup verification.

Authors:  D Vetterli; H Riem; D M Aebersold; R H Greiner; P Manser; P Cossmann; L Kemmerling; E J Born; R Mini
Journal:  Med Phys       Date:  2004-04       Impact factor: 4.071

3.  Relocatable frame for stereotactic external beam radiotherapy.

Authors:  S S Gill; D G Thomas; A P Warrington; M Brada
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-03       Impact factor: 7.038

4.  Radiobiological analysis of tissue responses following radiosurgery.

Authors:  John C Flickinger; Douglas Kondziolka; L Dade Lunsford
Journal:  Technol Cancer Res Treat       Date:  2003-04

Review 5.  The linear-quadratic formula and progress in fractionated radiotherapy.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  1989-08       Impact factor: 3.039

6.  Clinical outcome of hypofractionated conventional conformation radiotherapy for patients with single and no more than three metastatic brain tumors, with noninvasive fixation of the skull without whole brain irradiation.

Authors:  Masahiko Aoki; Yoshinao Abe; Yoshiomi Hatayama; Hidehiro Kondo; Kiyoshi Basaki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-03       Impact factor: 7.038

7.  Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance.

Authors:  Dennis C Shrieve; Lisa Hazard; Kenneth Boucher; Randy L Jensen
Journal:  J Neurosurg       Date:  2004-11       Impact factor: 5.115

8.  Noninvasive patient fixation for extracranial stereotactic radiotherapy.

Authors:  F Lohr; J Debus; C Frank; K Herfarth; O Pastyr; B Rhein; M L Bahner; W Schlegel; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

9.  Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Rikiya Onimaru; Kenji Kagei; Jun Ikeda; Nobuaki Ishii; Yutaka Sawamura; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

10.  Real-time tumor-tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopy.

Authors:  Toshiyuki Harada; Hiroki Shirato; Shigeaki Ogura; Satoshi Oizumi; Koichi Yamazaki; Shinichi Shimizu; Rikiya Onimaru; Kazuo Miyasaka; Masaharu Nishimura; Hirotoshi Dosaka-Akita
Journal:  Cancer       Date:  2002-10-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.